SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,551 Cr | ₹1,370 Cr | ₹1,421 Cr | ₹1,413 Cr | ₹1,362 Cr |
What is the latest Revenue of SEQUENT SCIENTIFIC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,551 Cr |
| Mar2024 | ₹1,370 Cr |
| Mar2023 | ₹1,421 Cr |
| Mar2022 | ₹1,413 Cr |
| Mar2021 | ₹1,362 Cr |
How is Revenue of SEQUENT SCIENTIFIC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,551 Cr | 13.26 | |
| Mar2024 | ₹1,370 Cr | -3.60 | |
| Mar2023 | ₹1,421 Cr | 0.57 | |
| Mar2022 | ₹1,413 Cr | 3.76 | |
| Mar2021 | ₹1,362 Cr | - | |
Compare Revenue of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹9,579.0 Cr | -2% | 8.1% | 48.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -2% |
8.1% |
48.5% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses